CLOT
Collaborative Learning on Thrombosis
Anticoagulation in 2016:
Concepts of Care for
Community-based
Primary Care Providers
EVENT TITLE
Saturday, May 28, 2016
8:00 a.m. – 1:00 p.m.
The Willows Golf Club
382 Cartwright Street
Saskatoon, Sask.
Register online: www.eply.com/CLOTWorkshop2016
Registration fee - $75.00/per person
Registration deadline Monday, May 23, 2016
*space is limited*
Pharmacists – this program is CPDP accredited for 3.25 CEUs
For more information email: CLOTpharmacists@gmail.com
CLOT initiatives are sponsored through unrestricted grants
by the following industry sponsors: Bayer, Boehringer
Ingelheim, Bristol Myers Squibb, Leo Pharma, Pfizer, Sanofi
CLOT Members
Jennifer Bolt, BScPharm, ACPR, PharmD (Planning Committee)
Residency and Education Coordinator
Regina Qu'Appelle Health Region
Cindy Jones, BScPharm
Site Lead Pharmacist/AMS Co-Ordinator
Athabasca Healthcare Centre, AHS
Darcy Lamb, BSP, ACPR, MSc (Planning Committee)
Clinical Co-ordinator Pharmacy Services
Saskatoon Health Region
Jennifer Lowerison, BScPharm, PharmD
Clinical Practice Leader, Program Liaison
Calgary Zone Anticoagulation Management Services, AHS
Wm. Semchuk, MSc, PharmD, FCSHP (Planning Committee)
Manager, Pharmacy Practice
Regina Qu’Appelle Health Region
Peter Thomson, BScPharm, PharmD
Interim Clinical Resource Pharmacist, Family Medicine Program
Winnipeg Regional Health Authority
Tammy J Bungard, BSP, PharmD
AMS Program Director, Associate Professor of Medicine
University of Alberta
Cynthia Brocklebank, PharmD, ACPR
Manager, Pharmacy Services
Alberta Health Services
Linda A. Sulz, BSP, PharmD (Planning Committee)
Pharmacy Manager, Strategic Initiatives, Outpatient & Antimicrobial
Services, Regina Qu'Appelle Health Region
Background
Symposium Schedule
AGENDA
8:00 a.m.
Registration
Continental Breakfast
The Collaborative Learning on Thrombosis (CLOT) group consists of
pharmacists from the Prairie Provinces with an interest or practice in
the management of thrombosis/anticoagulation therapies. It provides
a forum to network and gain expertise to facilitate knowledge transfer
to other pharmacists and healthcare practitioners to optimize the care
of patients with thromboembolic disease.
Primary Health Care providers such as community pharmacists and
Nurse Practitioners are some of the most accessible healthcare
professionals. With evolving roles and scopes of practice, taking a
proactive role in managing medications has become more important.
Anticoagulation management is a good example of this evolution with
more providers involved in both monitoring and managing
anticoagulation care. Much has changed over the past decade.
Warfarin and low molecular weight heparins still have a place in care
for many patients, and several novel oral anticoagulants (NOACs) are
now available for use in the prevention of stroke for atrial fibrillation
(AF) and the acute treatment/prevention of recurrent venous
thromboembolism (VTE). With the plethora of data, community
pharmacists and nurse practitioners are well situated to ensure
appropriate selection and ongoing monitoring of these agents.
This learning event will utilize case vignettes to provide up to date
information on anticoagulation therapies covering common
thrombosis topics relevant to a community-based primary care
practice.
Learning Objectives:
At the end of this session the learner will:
8:30 a.m.
Opening Remarks
8:40 a.m.
Anticoagulation Appetizer
9:10 a.m.
Current Concepts in Venous
Thromboembolism Treatment
9:40 a.m.
Atrial Fibrillation and Management
Considerations
10:10 a.m.
Break
Refreshments will be available at the scheduled break.
10:40 a.m.
Anticoagulation Tools and Tips to
help you in your Community
Practice, including rural perspective
11:10 a.m.
Treatment Transitions: The What,
Why, When, and How of Switching
and Interrupting NOAC therapy
11:40 a.m.
Bleeding/Reversal and Drug
Interactions with NOACs
12:10 p.m.
Question and Answers
12:40 p.m.
Program Evaluation